aferetica.com
ECCO₂R – Aferetica
http://www.aferetica.com/en/therapies/ecco-2r
Mini-invasive therapy with medium-low blood flow, which includes an oxygenator. The system allows removing carbon dioxide from hypercapnic patients permitting extended clinical use of non-invasive ventilation systems or protective ventilation strategies. Display the treated DISEASES. 2 ECCO R HF. Go to Aphercap page. May 17, 2016. January 14, 2015. 41037 Mirandola (MO) Italy. Tel: 39 0535 640261. Tel: 39 051 531362. For further information please contact our Customer Service:. Tel: 39 0587 489723. The in...
aferetica.com
Hemoperfusion – Aferetica
http://www.aferetica.com/en/therapies/hemoperfusion
This treatment uses an adsorbent cartridge capable of retaining specific molecules responsible for the development of particular diseases directly from the blood. Current technology allows identifying the molecules responsible for some diseases and producing specific sorbents able to retain them. Display the treated DISEASES. PlasmApher performs the following therapies:. Plasma separated via centrifuge or plasma filter). C) Double Filtration Adsorption. Go to Plasmapher page. Go to Leucapher page. Le inf...
aferetica.com
Immunoapheresis – Aferetica
http://www.aferetica.com/en/therapies/immunoapheresis
Immunoapheresis is a selective apheresis treatment performable on plasma thanks to the use of dextran sulphate (synthetic sulphurated polymer). Dextran sulphate can be used on plasma and the matrix pores allow selective removal based on the size of the target molecules. The plasma separated from the whole blood by centrifugation or filtration is conveyed to a column containing cellulose beads coated with dextran sulphate. Display the treated DISEASES. Aferesi ad elevate prestazioni:. Go to Kaneka page.
aferetica.com
Leucapher – Aferetica
http://www.aferetica.com/en/products/leucapher
Thanks to a pre-dilution system, you can perform short outpatient therapies using a simple peripheral access, allowing mini-invasiveness associated with maximum safety. LeucApher has only two pumps which allow moving the blood with flows variable between 5 and 150ml/min and controlling the heparinated infusion fluid with the aim of encouraging anticoagulation and aspiration of the blood. Dedicated safety systems favour a successful outcome of the therapy. Display the treated DISEASES. May 17, 2016. This ...
aferetica.com
Therapies – Aferetica
http://www.aferetica.com/en/therapies
May 17, 2016. January 14, 2015. 41037 Mirandola (MO) Italy. Tel: 39 0535 640261. Tel: 39 051 531362. For further information please contact our Customer Service:. Tel: 39 0587 489723. Fax: 39 0587 489808. This website does NOT use any profiling cookie to send you advertising in line with your preferences. Only technical cookies are used. There may be third-party cookies related to videos, maps or social plugins. If you access any site element, you consent to cookies to this website. The information poste...
aferetica.com
TRANSPLANTATION – Aferetica
http://www.aferetica.com/en/transplantation
TRANSPLANT: GIVE MORE POSSIBILITIES TO LIFE. The shortage of suitable organs. For transplantation meets an ever higher demand. The consequence is that waiting lists are getting longer. On one hand, there is the need to ensure the use of every organ. Even the marginal ones. Compromised by complex biological reactions and processes characterizing organ retrieval and storage, on the other, the outcome. Of the transplantation must be improved. Wants to contribute to a concrete change. The evolution of In Situ.
aferetica.com
WHO WE ARE – Aferetica
http://www.aferetica.com/en/who-we-are
We are an innovative startup, recognised as such on regional and national level, founded by operators and managers with decades of experience in dialysis, intensive care, cardiology, and medical devices in general. We have strongly and physically set up in the incubator of the Biomedical District of Mirandola. This district has the knowledge, technologies, enterprises and production capacities that allow us to quickly and efficiently develop therapies and products giving new stimulus and creating new jobs.
aferetica.com
ECCO₂R – Aferetica
http://www.aferetica.com/en/therapies/ecco₂rhf
Mini-invasive therapy with medium-low blood flow, which includes an oxygenator. The system allows removing carbon dioxide from hypercapnic patients permitting extended clinical use of non-invasive ventilation systems or protective ventilation strategies. Display the treated DISEASES. 2 ECCO R HF. Go to Aphercap page. May 17, 2016. January 14, 2015. 41037 Mirandola (MO) Italy. Tel: 39 0535 640261. Tel: 39 051 531362. For further information please contact our Customer Service:. Tel: 39 0587 489723. The in...
aferetica.com
Rheopheresis – Aferetica
http://www.aferetica.com/en/therapies/rheopheresis
The Rheopheresis treatment reinfuses the plasma to the patient after its purification either by filtration or adsorption. The plasma is separated from the blood through a plasma filter or with a centrifuge system. The plasma is then treated with filters with different cut-off or with selective sorbents or both (therapy introduced by Aferetica). Contrary to plasma exchange, this technique does not infuse replacement substances and is therefore highly biocompatible and well-tolerated by the patient. Le inf...
aferetica.com
Double Filtration Adsorption – Aferetica
http://www.aferetica.com/en/therapies/double-filtration-adsorption
The Double Filtration Adsorption therapy (introduced by Aferetica) is a combined treatment of the plasma coming from a plasma filter or centrifuge using a fractionation filter and a sorbent cartridge. This therapy allows combining the benefits of reduced blood viscosity with the consequent improvement in microcirculation with those of purification by adsorption of molecules such as cytokines related to the inflammatory process. Display the treated DISEASES. PlasmApher performs the following therapies:.
